RBBP6 increases radioresistance and serves as a therapeutic target for preoperative radiotherapy in colorectal cancer.
Xiao C, Wang Y, Zheng M, Chen J, Song G, Zhou Z, Zhou C, Sun X, Zhong L, Ding E, Zhang Y, Yang L, Wu G, Xu S, Zhang H, Wang X.
Xiao C, et al. Among authors: zhou z, zhou c.
Cancer Sci. 2018 Apr;109(4):1075-1087. doi: 10.1111/cas.13516. Epub 2018 Mar 10.
Cancer Sci. 2018.
PMID: 29369481
Free PMC article.